Searched for
GENERIC MIGRAINE DRUG
From oncology to obesity, Pfizer bets big on India for its next growth wavePfizer is prioritizing India for future growth. The company plans to launch new medicines here soon after their global release. Pfizer aims...- US market today: Pfizer posts strong first-quarter, sees boost from recent legal winsPfizer reported higher-than-expected sales and profit on Tuesday and said a patent extension for its Vyndamax heart drug and a recent favor...
- Alembic Pharmaceuticals gets USFDA nod for generic migraine treatment injectionAlembic Pharmaceuticals has achieved a pivotal milestone with the final green light from the US health authority for its generic Sumatripta...
- Cipla gets USFDA nod for migraine drugThe newly approved product is a generic therapeutic equivalent version of GlaxoSmithKline's Imitrex Nasal Spray.
- Panacea Biotec enters collaboration with Bionpharma for generics worth $800 millionShare prices spiked upon the development, going as high as 9.75% (Rs 148 a piece) on the Bombay Stock Exchange before 11:00 am on Friday.
- Panacea inks pact with UNICEF,gets USFDA nod for migraine drugPanacea's product is equivalent to Merck & Co's Maxalt-MLT tablets. The drug has annual sales for around USD 60 million in the US market.
- Ajanta Pharma gets USFDA nod for migraine pain relief drugAjanta Pharma has received final approval for its generic version of acute migraine pain relief drug Zolmitriptan tablets from the US healt...
- Aurobindo Pharma gets USFDA nod for generic migraine drugThe company's product is the generic equivalent of IPR Pharmaceuticals' Zomig, which is used in the treatment of migraine in adults.
- Ajanta Pharma shares jump nearly 4% on USFDA nod for drugThe stock went up 3.69 per cent to Rs 1,448.80 on BSE.
- Ajanta Pharma gets USFDA nod for migraine pain relief drugThe approval is for multiple strengths of 6.25mg and 12.5mg of the generic version of Janssen Pharmaceuticals' Axert tablets, Ajanta Pharma...
- Dr Reddy’s goes beyond generic products, gets nod for two branded drugsThe approvals have come at a time when Indian drug companies are facing the FDA’s ire for non-compliance of good manufacturing process.
- Jubilant Life Sciences gets USFDA nod for migraine treatment drugJubilant Life Sciences announced approval from the US health regulator for its generic version of Merck's acute migraine treatment medicine.
- Jubilant Life gets USFDA nod for anti-migraine tabletsJubilant Life Sciences today said it has received US health regulator's nod to market its generic zolmitriptan orally disintegrating tablet...
- Jubilant Life Sciences gets FDA nod for Mycophenolate Mofetil & RizatriptanThe approvals are for Mycophenolate Mofetil in the strengths of 250 mg capsules and 500 mg tablets and Rizatriptan tablets in strengths of ...
- Glenmark gets USFDA approval for headache drug"Glenmark will commence distribution of the product immediately," the Mumbai-based firm said.
- Aurobindo Pharma gets USFDA nod for anti-migraine tabletsThe product which was tentatively approved by the FDA earlier, is ready for launch, a statement from Aurobindo said.
- Glenmark gets tentative nod from USFDA for migraine tabletsGlenmark today said it has received tentative approval from USFDA for its generic Rizatriptan Benzoate tablet.
- Glenmark gets tentative nod from USFDA for migraine tabletsGlenmark Pharmaceuticals said it has received tentative approval from the US health regulator for generic Zolmitriptan tablets used for tre...
- Glenmark US arm gets tentative USFDA nod for migraine tabletsGlenmark said its US subsidiary has received tentative approval from the US health regulator for its generic Zolmitriptan tablets.
- Sun Pharma gets USFDA approval for migraine injectionSun Pharma said it has received the USFDA approval for the launch of its generic Sumatriptan Succinate injections in the American market.
Load More
